Melcap Systems

Company Overview

Snapshot

Founded in November 2011 by Boris Voznesensky and Rami Eliakim, Melcap Systems operates with 1–10 employees. The company has raised $2.6 million across two funding rounds from one investor. In December 2015, the company secured funding from Roman Abramovich.

Business overview

Melcap Systems is a Health Tech & Life Sciences company focused on developing a noninvasive system for treating obesity. Its core technology involves a disposable, ingestible stimulating capsule with variable volume that can be wirelessly guided and fixed in the gastrointestinal tract using an external magnetic system. The company aims to address the global obesity epidemic, serving patients and healthcare providers within the medical devices, digital therapeutics, and digital healthcare sectors.

Strategic signal

In December 2022, Melcap Systems ceased operations, indicating a significant strategic shift for the company. This event signals to investors and innovation teams that the company is no longer actively pursuing its mission to combat the global obesity epidemic with its noninvasive treatment system.

Company Intelligence Q&A

What is Melcap Systems' primary focus?

Melcap Systems develops a noninvasive system for treating overweight and obesity using a wirelessly guided, ingestible stimulating capsule.

When was Melcap Systems founded?

Melcap Systems was founded in November 2011.

Who are the founders of Melcap Systems?

Boris Voznesensky and Rami Eliakim are the co-founders of Melcap Systems.

What is the current operational status of Melcap Systems?

Melcap Systems ceased to operate in December 2022.